Literature DB >> 11175672

Effects of radiation on tumor intravascular oxygenation, vascular configuration, development of hypoxia, and clonogenic survival.

B M Fenton1, E M Lord, S F Paoni.   

Abstract

The underlying physiological mechanisms leading to tumor reoxygenation after irradiation have elicited considerable interest, but they remain somewhat unclear. The current study was undertaken to determine the effects of a single dose of 10 Gy gamma radiation on both tumor pathophysiology and radiobiologically hypoxic fraction. Immunohistochemical staining and perfusion markers were used to quantify tumor vasculature, uptake of the hypoxia marker EF5 to assess the distribution of hypoxia, and intravascular HbO(2) measurements to determine oxygen availability. Tumor radiosensitivity was measured by a clonogenic assay. At 24 h postirradiation, oxygen availability increased, perfused vessel numbers decreased, EF5 uptake decreased, and the radiobiologically hypoxic fraction was unchanged. Together, these results demonstrate that tumor hypoxia develops at an increased distance from perfused blood vessels after irradiation, suggesting a decrease in oxygen consumption at 24 h. By 72 h postirradiation, all physiological parameters had returned to the levels in volume-matched, nonirradiated controls. These studies clearly show that single measures of either tumor oxygenation or vascular structure are inadequate for assessing the effects of radiation on tumor clonogenicity. Although such direct measurements have previously proven valuable in predicting tumor response to therapy or oxygen manipulation, a combination of parameters is required to adequately describe the mechanisms underlying these changes after irradiation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11175672     DOI: 10.1667/0033-7587(2001)155[0360:eoroti]2.0.co;2

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  11 in total

1.  Tissue oxygenation in a murine SCC VII tumor after X-ray irradiation as determined by EPR spectroscopy.

Authors:  Hirotada Fujii; Koh-Ichi Sakata; Yoshihiro Katsumata; Rikiya Sato; Makoto Kinouchi; Masanori Someya; Shin-Ichiro Masunaga; Masato Hareyama; Harold M Swartz; Hiroshi Hirata
Journal:  Radiother Oncol       Date:  2008-02-20       Impact factor: 6.280

2.  Alterations in daily sequencing of axitinib and fractionated radiotherapy do not affect tumor growth inhibition or pathophysiological response.

Authors:  Bruce M Fenton; Scott F Paoni
Journal:  Radiat Res       Date:  2009-05       Impact factor: 2.841

3.  Intratumoral Hypoxia Reduces IFN-γ-Mediated Immunity and MHC Class I Induction in a Preclinical Tumor Model.

Authors:  Aditi Murthy; Scott A Gerber; Cameron J Koch; Edith M Lord
Journal:  Immunohorizons       Date:  2019-04-29

4.  Spatio-Temporal Dynamics of Hypoxia during Radiotherapy.

Authors:  Harald Kempf; Marcus Bleicher; Michael Meyer-Hermann
Journal:  PLoS One       Date:  2015-08-14       Impact factor: 3.240

5.  Preclinical longitudinal imaging of tumor microvascular radiobiological response with functional optical coherence tomography.

Authors:  Valentin Demidov; Azusa Maeda; Mitsuro Sugita; Victoria Madge; Siddharth Sadanand; Costel Flueraru; I Alex Vitkin
Journal:  Sci Rep       Date:  2018-01-08       Impact factor: 4.379

6.  Effects of light fractionation and different fluence rates on photodynamic therapy with 5-aminolaevulinic acid in vivo.

Authors:  P Babilas; V Schacht; G Liebsch; O S Wolfbeis; M Landthaler; R-M Szeimies; C Abels
Journal:  Br J Cancer       Date:  2003-05-06       Impact factor: 7.640

Review 7.  Modelling tumour oxygenation, reoxygenation and implications on treatment outcome.

Authors:  Iuliana Toma-Dasu; Alexandru Dasu
Journal:  Comput Math Methods Med       Date:  2013-01-14       Impact factor: 2.238

8.  Zonal image analysis of tumour vascular perfusion, hypoxia, and necrosis.

Authors:  B M Fenton; S F Paoni; B K Beauchamp; I Ding
Journal:  Br J Cancer       Date:  2002-06-05       Impact factor: 7.640

9.  Overexpression of VEGF121, but not VEGF165 or FGF-1, improves oxygenation in MCF-7 breast tumours.

Authors:  B M Fenton; S F Paoni; W Liu; S-Y Cheng; B Hu; I Ding
Journal:  Br J Cancer       Date:  2004-01-26       Impact factor: 7.640

10.  Radiation therapy combined with Listeria monocytogenes-based cancer vaccine synergize to enhance tumor control in the B16 melanoma model.

Authors:  Joanne Yh Lim; Dirk G Brockstedt; Edith M Lord; Scott A Gerber
Journal:  Oncoimmunology       Date:  2014-06-03       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.